A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway

Background: The extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. (ESZM) is a formula composed of Euphorbia fischeriana Steud. (E. fischeriana) and Ziziphus jujuba Mill. (Z. jujuba). Previous studies have shown that the ESZM extract has good anti-breast cancer effects in vitro. Howev...

Full description

Bibliographic Details
Main Authors: Liwei Ma, Zhe Chen, Meiyu Feng, Qi Liu, Yu Sun, Wenbao Wang, Jinling Zhang, Hongtao Zhang, Yajie Liang, Jicheng Liu
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Pharmacological Research - Modern Chinese Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667142522001579
_version_ 1811178163168870400
author Liwei Ma
Zhe Chen
Meiyu Feng
Qi Liu
Yu Sun
Wenbao Wang
Jinling Zhang
Hongtao Zhang
Yajie Liang
Jicheng Liu
author_facet Liwei Ma
Zhe Chen
Meiyu Feng
Qi Liu
Yu Sun
Wenbao Wang
Jinling Zhang
Hongtao Zhang
Yajie Liang
Jicheng Liu
author_sort Liwei Ma
collection DOAJ
description Background: The extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. (ESZM) is a formula composed of Euphorbia fischeriana Steud. (E. fischeriana) and Ziziphus jujuba Mill. (Z. jujuba). Previous studies have shown that the ESZM extract has good anti-breast cancer effects in vitro. However, its in vivo therapeutic efficacy and underlying mechanism are still unclear, particularly for different subtypes of breast cancer. Our study aimed to investigate the pharmacological effects and the underlying molecular mechanism of the ESZM extract on growth inhibition and apoptosis in breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells Methodology: In this paper, growth inhibition, cell cycle arrest and apoptosis of tumour tissues treated with the ESZM extract in ER(+) or ER(-) breast cancer xenografts were determined based on the tumour inhibition rates, using a cycle analysis kit, Annexin V-FITC/PI and Hoechst 33,342/PI staining and TEM observations, and a TUNEL test. The related gene and protein expression levels were measured using a qRT-PCR assay, Western blotting, immunohistochemistry and immunofluorescence. Serum biochemistry tests and H&E staining were performed to evaluate the toxicity of the ESZM extract. Results: The results showed that the ESZM extract could inhibit the cell growth, block the cell cycle at the G2/M phase, and induce the apoptosis of subcutaneously transplanted tumours, especially of ER(-) breast cancer transplanted tumours. Furthermore, we demonstrated that the polyjuice could down-regulate or up-regulate the expression of the Bcl-2 family factors and of PI3k/Akt pathway-related signalling molecules in vivo. The ESZM extract increased the levels of ALT, AST, Cr and BUN, and increased the hepatic and renal toxicity in cancer-bearing mice. Conclusions: these experimental results indicate that the ESZM extract has significant anti-breast cancer effects, particularly in ER(-) breast cancer xenografts, which might be implemented through the mitochondrion-dependant and the PI3k/Akt signalling pathways. The toxicity tests showed that the ESZM extract may have hepatorenal toxicity. Finally, we believe that the ESZM extract can be developed as a novel therapeutic option for the treatment of breast carcinoma.
first_indexed 2024-04-11T06:14:55Z
format Article
id doaj.art-10109a405bd6410e88effd67e9e14056
institution Directory Open Access Journal
issn 2667-1425
language English
last_indexed 2024-04-11T06:14:55Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Pharmacological Research - Modern Chinese Medicine
spelling doaj.art-10109a405bd6410e88effd67e9e140562022-12-22T04:41:06ZengElsevierPharmacological Research - Modern Chinese Medicine2667-14252022-12-015100198A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathwayLiwei Ma0Zhe Chen1Meiyu Feng2Qi Liu3Yu Sun4Wenbao Wang5Jinling Zhang6Hongtao Zhang7Yajie Liang8Jicheng Liu9Qiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaHarbin Red Cross Central Hospital, Heilongjiang Harbin, 150076, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaThe third affiliated hospital of Qiqihaer Medical University, Heilongjiang Qiqihaer, 163001, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, ChinaQiqihaer Medical University, Heilongjiang Qiqihaer, 161006, China; Corresponding author.Background: The extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. (ESZM) is a formula composed of Euphorbia fischeriana Steud. (E. fischeriana) and Ziziphus jujuba Mill. (Z. jujuba). Previous studies have shown that the ESZM extract has good anti-breast cancer effects in vitro. However, its in vivo therapeutic efficacy and underlying mechanism are still unclear, particularly for different subtypes of breast cancer. Our study aimed to investigate the pharmacological effects and the underlying molecular mechanism of the ESZM extract on growth inhibition and apoptosis in breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells Methodology: In this paper, growth inhibition, cell cycle arrest and apoptosis of tumour tissues treated with the ESZM extract in ER(+) or ER(-) breast cancer xenografts were determined based on the tumour inhibition rates, using a cycle analysis kit, Annexin V-FITC/PI and Hoechst 33,342/PI staining and TEM observations, and a TUNEL test. The related gene and protein expression levels were measured using a qRT-PCR assay, Western blotting, immunohistochemistry and immunofluorescence. Serum biochemistry tests and H&E staining were performed to evaluate the toxicity of the ESZM extract. Results: The results showed that the ESZM extract could inhibit the cell growth, block the cell cycle at the G2/M phase, and induce the apoptosis of subcutaneously transplanted tumours, especially of ER(-) breast cancer transplanted tumours. Furthermore, we demonstrated that the polyjuice could down-regulate or up-regulate the expression of the Bcl-2 family factors and of PI3k/Akt pathway-related signalling molecules in vivo. The ESZM extract increased the levels of ALT, AST, Cr and BUN, and increased the hepatic and renal toxicity in cancer-bearing mice. Conclusions: these experimental results indicate that the ESZM extract has significant anti-breast cancer effects, particularly in ER(-) breast cancer xenografts, which might be implemented through the mitochondrion-dependant and the PI3k/Akt signalling pathways. The toxicity tests showed that the ESZM extract may have hepatorenal toxicity. Finally, we believe that the ESZM extract can be developed as a novel therapeutic option for the treatment of breast carcinoma.http://www.sciencedirect.com/science/article/pii/S2667142522001579Extract of Euphorbia fischeriana SteudAnd Ziziphus jujuba MillER(-) breast cancerNude micePI3k/Akt signalling pathwayCombat poison with poison
spellingShingle Liwei Ma
Zhe Chen
Meiyu Feng
Qi Liu
Yu Sun
Wenbao Wang
Jinling Zhang
Hongtao Zhang
Yajie Liang
Jicheng Liu
A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
Pharmacological Research - Modern Chinese Medicine
Extract of Euphorbia fischeriana Steud
And Ziziphus jujuba Mill
ER(-) breast cancer
Nude mice
PI3k/Akt signalling pathway
Combat poison with poison
title A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
title_full A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
title_fullStr A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
title_full_unstemmed A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
title_short A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
title_sort diverse treatment with the extract of euphorbia fischeriana steud and ziziphus jujuba mill for breast cancer nude mice of mcf 7 er cells or mda mb 453 er cells via modulation of the pi3k akt signalling pathway
topic Extract of Euphorbia fischeriana Steud
And Ziziphus jujuba Mill
ER(-) breast cancer
Nude mice
PI3k/Akt signalling pathway
Combat poison with poison
url http://www.sciencedirect.com/science/article/pii/S2667142522001579
work_keys_str_mv AT liweima adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT zhechen adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT meiyufeng adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT qiliu adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT yusun adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT wenbaowang adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT jinlingzhang adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT hongtaozhang adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT yajieliang adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT jichengliu adiversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT liweima diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT zhechen diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT meiyufeng diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT qiliu diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT yusun diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT wenbaowang diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT jinlingzhang diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT hongtaozhang diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT yajieliang diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway
AT jichengliu diversetreatmentwiththeextractofeuphorbiafischerianasteudandziziphusjujubamillforbreastcancernudemiceofmcf7ercellsormdamb453ercellsviamodulationofthepi3kaktsignallingpathway